Background: Prophylactic mastectomies in carriers of mutations in BRCA1 or BRCA2 are becoming increasingly more accepted. We investigated the outcome after prophylactic mastectomy, especially regarding satisfaction with the procedure, in a monocenter study. Methods: BRCA1/2 mutation carriers and non-carriers with elevated pedigree-based cancer risk were followed prospectively in a structured surveillance program between 2000 and 2017. A retrospective telephone survey was conducted among all patients with documented prophylactic mastectomy. Complications and satisfaction with the decision for prophylactic mastectomy were recorded. Results: 39 patients who opted for a prophylactic mastectomy (38 BRCA1/2 mutation carriers and 1 noncarrier) w...
Background: Prophylactic or ‘risk-reducing’ mastectomy refers to the procedure of completely removin...
Women with a suspected BRCA1/2-mutation may choose between two management options: breast cancer scr...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...
Background: Prophylactic mastectomies in carriers of mutations in BRCA1 or BRCA2 are becoming increa...
Background: Although demand for prophylactic mastectomy is increasing over time among women at a hig...
Background: Although demand for prophylactic mastectomy is increasing over time among women at a hig...
Abstract BACKGROUND: Although demand for prophylactic mastectomy is increasing over time among wom...
AIM: To examine the outcome of prophylactic mastectomy in a hospital-based series of BRCA1/2 gene mu...
Importance: Nipple-sparing mastectomy (NSM) offers superior cosmetic outcomes and has been gaining ...
textabstractBackground: BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cance...
Contains fulltext : 88586.pdf (publisher's version ) (Closed access)Women with a B...
Women with a BRCA mutation face a complex choice between breast cancer surveillance and prophylactic...
Background BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cancer family have...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
Background: Prophylactic or ‘risk-reducing’ mastectomy refers to the procedure of completely removin...
Women with a suspected BRCA1/2-mutation may choose between two management options: breast cancer scr...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...
Background: Prophylactic mastectomies in carriers of mutations in BRCA1 or BRCA2 are becoming increa...
Background: Although demand for prophylactic mastectomy is increasing over time among women at a hig...
Background: Although demand for prophylactic mastectomy is increasing over time among women at a hig...
Abstract BACKGROUND: Although demand for prophylactic mastectomy is increasing over time among wom...
AIM: To examine the outcome of prophylactic mastectomy in a hospital-based series of BRCA1/2 gene mu...
Importance: Nipple-sparing mastectomy (NSM) offers superior cosmetic outcomes and has been gaining ...
textabstractBackground: BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cance...
Contains fulltext : 88586.pdf (publisher's version ) (Closed access)Women with a B...
Women with a BRCA mutation face a complex choice between breast cancer surveillance and prophylactic...
Background BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cancer family have...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
Background: Prophylactic or ‘risk-reducing’ mastectomy refers to the procedure of completely removin...
Women with a suspected BRCA1/2-mutation may choose between two management options: breast cancer scr...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...